The inflammatory component of Kaposi sarcoma

被引：10

作者：

Pantanowitz, Liron ^{[1
]}

Moses, Ashlee V. ^{[2
]}

Dezube, Bruce J. ^{[3
]}

机构：

[1] Baystate Med Ctr, Dept Pathol, Springfield, MA 01199 USA

[2] Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Beaverton, OR USA

[3] Harvard Univ, Beth Israel Deaconess Med Ctr, Dept Med, Sch Med, Boston, MA 02215 USA

来源：

EXPERIMENTAL AND MOLECULAR PATHOLOGY | 2009年 / 87卷 / 02期

关键词：

Inflammation; Immunity; Dendritic cell; KSHV; HHV8; Granuloma; DERMAL DENDROCYTES; DENDRITIC CELLS; PATHOGENESIS; AIDS;

D O I：

10.1016/j.yexmp.2009.07.001

中图分类号：

R36 [病理学];

学科分类号：

100104 ;

摘要：

Kaposi sarcoma (KS) is intimately linked to several aspects of the host immune system. KS development is linked to immunodeficiency in several clinical-epidemiological settings. The development of KS at local inflammatory sites has also been documented. Inflammatory cells are almost always present within KS lesions. Depending upon the inflammatory milieu, KS lesions may progress or regress. Not surprisingly, iatrogenic manipulation of host immunity with drugs may provoke KS growth and/or flare. Given the close association between KS and the immune system, the etiologic agent Kaposi Sarcoma Herpesvirus has developed a variety of mechanisms to evade the host immune system, all of which have cleverly evolved to promote oncogenesis and viral persistence. (C) 2009 Elsevier Inc. All rights reserved.

引用

页码：163 / 165

页数：3

共 26 条

[1]

Bedani PL, 1999, J NEPHROL, V12, P193

[2] Immune reconstitution inflammatory syndrome associated with Kaposi's sarcoma [J].

Bower, M ;

Nelson, M ;

Young, AM ;

Thirlwell, C ;

Newsom-Davis, T ;

Mandalia, S ;

Dhillon, T ;

Holmes, P ;

Gazzard, BG ;

Stebbing, J .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (22) :5224-5228

[3] SARCOID REACTIONS IN MALIGNANT-TUMORS [J].

BRINCKER, H .

CANCER TREATMENT REVIEWS, 1986, 13 (03) :147-156

[4] Virologic, hematologic, and immunologic risk factors for classic Kaposi sarcoma [J].

Brown, Elizabeth E. ;

Whitby, Denise ;

Vitale, Francesco ;

Marshall, Vickie ;

Mbisa, Georgina ;

Gamache, Christine ;

Lauria, Carmela ;

Alberg, Anthony J. ;

Serraino, Diego ;

Cordiali-Fei, Paola ;

Messina, Angelo ;

Goedert, James J. .

CANCER, 2006, 107 (09) :2282-2290

[5] Progression of classic Kaposi's sarcoma with rituximab [J].

Clifford, KS ;

Demierre, MF .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2005, 53 (01) :155-157

[6] ORIGIN OF KAPOSIS SARCOMA FROM RETICULO-ENDOTHELIAL SYSTEM [J].

DAYAN, AD ;

LEWIS, PD .

NATURE, 1967, 213 (5079) :889-&

[7] Quantitative and functional defects of dendritic cells in classic Kaposi's sarcoma [J].

Della Bella, Silvia ;

Nicola, Stefania ;

Brambilla, Lucia ;

Riva, Antonio ;

Ferrucci, Silvia ;

Presicce, Pietro ;

Boneschi, Vinicio ;

Berti, Emilio ;

Villa, Maria Luisa .

CLINICAL IMMUNOLOGY, 2006, 119 (03) :317-329

[8]

Dezube BJ, 2000, SEMIN ONCOL, V27, P420

[9]

Douglas JL, 2007, PANMINERVA MED, V49, P119

[10] Cutaneous cryptococcosis and Kaposi's sarcoma occurring in the same lesions in a patient with the acquired immunodeficiency syndrome [J].

Glassman, SJ ;

Hale, MJ .

CLINICAL AND EXPERIMENTAL DERMATOLOGY, 1995, 20 (06) :480-486

← 1 2 3 →